The Effect of Vitamin D Supplementation on Atopic  Dermatitis by Rafalovich, Nell
Pacific University
CommonKnowledge
School of Physician Assistant Studies Theses, Dissertations and Capstone Projects
Summer 8-8-2015
The Effect of Vitamin D Supplementation on
Atopic Dermatitis
Nell Rafalovich
Follow this and additional works at: http://commons.pacificu.edu/pa
Part of the Medicine and Health Sciences Commons
This Capstone Project is brought to you for free and open access by the Theses, Dissertations and Capstone Projects at CommonKnowledge. It has
been accepted for inclusion in School of Physician Assistant Studies by an authorized administrator of CommonKnowledge. For more information,
please contact CommonKnowledge@pacificu.edu.
Recommended Citation
Rafalovich, Nell, "The Effect of Vitamin D Supplementation on Atopic Dermatitis" (2015). School of Physician Assistant Studies. Paper
511.
The Effect of Vitamin D Supplementation on Atopic Dermatitis
Abstract
Background: Atopic dermatitis is a very common dermatological condition affecting adults and up to 20% of
children. Atopic dermatitis is thought to be regulated by the innate immune system which is controversially
affected by vitamin supplements, specifically vitamin D. Does vitamin D supplementation improve symptoms
of atopic dermatitis?
Methods: An exhaustive medical literature search was completed utilizing the following databases: Medline-
OVID, Web of Science, and CINAHL. The terms “vitamin D” and “atopic dermatitis” were used and linked to
further specify the search terms. The GRADE system for assessing research quality was used to determine
strength of studies’ findings.
Results: Two studies were selected using the systematic review inclusion criteria for the review. One random
control trial (RCT), of moderate GRADE quality, found a statistically significant improvement in atopic
dermatitis symptomology with patients suffering from mild, moderate, and severe eczema on a vitamin D
supplementation. The second RCT examined (also moderate in GRADE) did not show a significant
improvement in symptoms with vitamin D supplementation, however, some improvements were noted and
the authors suggest more research on the topic.
Conclusion: Vitamin D supplementation may cause a slight improvement in symptoms of atopic dermatitis
but more research is needed to prove a direct link and to provide dosing guidelines in order for this
recommendation to be adopted by medical providers.
Keywords: vitamin D, atopic dermatitis, supplementation, eczema, innate immunity
Degree Type
Capstone Project
Degree Name
Master of Science in Physician Assistant Studies
First Advisor
Annjanette Sommers, MS, PA-C
Keywords
atopic dermatitis, eczema, skin, rash, vitamin D, supplementation
Subject Categories
Medicine and Health Sciences
Rights
Terms of use for work posted in CommonKnowledge.
This capstone project is available at CommonKnowledge: http://commons.pacificu.edu/pa/511
Copyright and terms of use
If you have downloaded this document directly from the web or from CommonKnowledge, see the
“Rights” section on the previous page for the terms of use.
If you have received this document through an interlibrary loan/document delivery service, the
following terms of use apply:
Copyright in this work is held by the author(s). You may download or print any portion of this document
for personal use only, or for any use that is allowed by fair use (Title 17, §107 U.S.C.). Except for personal
or fair use, you or your borrowing library may not reproduce, remix, republish, post, transmit, or
distribute this document, or any portion thereof, without the permission of the copyright owner. [Note:
If this document is licensed under a Creative Commons license (see “Rights” on the previous page)
which allows broader usage rights, your use is governed by the terms of that license.]
Inquiries regarding further use of these materials should be addressed to: CommonKnowledge Rights,
Pacific University Library, 2043 College Way, Forest Grove, OR 97116, (503) 352-7209. Email inquiries
may be directed to:. copyright@pacificu.edu
This capstone project is available at CommonKnowledge: http://commons.pacificu.edu/pa/511
 
 
NOTICE TO READERS 
 
This work is not a peer-reviewed publication.  The Master’s Candidate author of this 
work has made every effort to provide accurate information and to rely on authoritative 
sources in the completion of this work.  However, neither the author nor the faculty 
advisor(s) warrants the completeness, accuracy or usefulness of the information provided 
in this work.  This work should not be considered authoritative or comprehensive in and 
of itself and the author and advisor(s) disclaim all responsibility for the results obtained 
from use of the information contained in this work.  Knowledge and practice change 
constantly, and readers are advised to confirm the information found in this work with 
other more current and/or comprehensive sources. 
 
The student author attests that this work is completely his/her original authorship and that 
no material in this work has been plagiarized, fabricated or incorrectly attributed.         
 
 The Effect of Vitamin D Supplementation on Atopic  
Dermatitis 
 
 
 
 
 
 
 
 
 
Nell Rafalovich 
 
 
 
 
 
 
 
 
 
A Clinical Graduate Project Submitted to the Faculty of the 
School of Physician Assistant Studies 
Pacific University 
Hillsboro, OR 
For the Masters of Science Degree, August 08, 2015 
 
Faculty Advisors: Dr. Vo & Prof. Olson 
Clinical Graduate Project Coordinator: Annjanette Sommers, PA-C, MS 
 2 
 
Biography 
 
Nell Rafalovich is a first-generation college student who has a background in diet and 
exercise counseling, cardiac rehabilitation, and exercise science with a BS from Southern 
Oregon University and a MS from Texas Tech University. She was born in Helena, MT 
and travelled extensively with migrant working parents until settling in southern Oregon 
as a youth. Her nontraditional upbringing gave opportunities to volunteer in India for 
three months, work in Germany as an au pair for a summer, and later she lived in 
Vietnam for six months as a college student studying the Vietnamese language and their 
medical practices. After completion of her Masters of Science in Texas, she chose to stay 
home with her two young sons for six years. She currently enjoys studying medicine and 
spending time with her husband and two sons. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3 
Abstract   
 
Background: Atopic dermatitis is a very common dermatological condition affecting 
adults and up to 20% of children. Atopic dermatitis is thought to be regulated by the 
innate immune system which is controversially affected by vitamin supplements, 
specifically vitamin D. Does vitamin D supplementation improve symptoms of atopic 
dermatitis? 
 
Methods: An exhaustive medical literature search was completed utilizing the following 
databases: Medline-OVID, Web of Science, and CINAHL. The terms “vitamin D” and 
“atopic dermatitis” were used and linked to further specify the search terms. The GRADE 
system for assessing research quality was used to determine strength of studies’ findings.  
 
Results:  Two studies were selected using the systematic review inclusion criteria for the 
review. One random control trial (RCT), of moderate GRADE quality, found a 
statistically significant improvement in atopic dermatitis symptomology with patients 
suffering from mild, moderate, and severe eczema on a vitamin D supplementation. The 
second RCT examined (also moderate in GRADE) did not show a significant 
improvement in symptoms with vitamin D supplementation, however, some 
improvements were noted and the authors suggest more research on the topic.  
 
Conclusion: Vitamin D supplementation may cause a slight improvement in symptoms 
of atopic dermatitis but more research is needed to prove a direct link and to provide 
dosing guidelines in order for this recommendation to be adopted by medical providers. 
 
Keywords:  vitamin D, atopic dermatitis, supplementation, eczema, innate immunity 
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The Effects of Vitamin D Supplementation on Atopic 
Dermatitis 
BACKGROUND 
 Atopic dermatitis (AD) also known as eczema is one of the most common skin 
disorders in children and adults, with a steep rise in diagnoses in children.1,2 Up to 20% 
of children are now affected in developing countries.3 Atopic dermatitis is a chronic and 
relapsing disease that is associated with inflammatory processes that often precedes 
asthma and allergic reactions. Patients with atopic dermatitis have a greater chance of 
acquiring infection by microbial organisms such as Staphylococcus aureus and herpes 
simplex virus due to defects in the innate immune system.4  
 Treatment strategies have often focused on allergy avoidance or topical 
application of medications but now research has shifted to the connection to immune 
function and the skin’s natural role as a barrier.3 Atopic dermatitis is not only associated 
with defects in the immune system but often these defects worsen inflammation.5 Within 
the past five years, focus has moved from the known interactions of vitamin D and bone 
mineralization and osteoporosis to a broader role including cardiovascular, endocrine, 
cancers, and chronic diseases such as hypertension.6 Vitamin D appears to have important 
roles in the immunity, namely improving the innate and adaptive immune responses. In 
fact, vitamin D supplementation has been used to treat tuberculosis.5 Researchers are now 
interested in this relationship and some support the hypothesis that vitamin D 
insufficiency interferes with the innate immune system and may be an underlying cause 
of infectious disease and immune disorders.6 The innate immune system is responsible 
for the signaling of antimicrobial activity and antigen presentation.4  
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 It is known that vitamin D also induces cathelicidin production.7 Cathelicidins are 
antimicrobial peptides that are involved with the defense against skin infections which 
are one of the exacerbating factors and causes of resistance to steroid therapy in atopic 
dermatitis.8 Cathelicidin production is one piece of the immunity puzzle. 
 Because of vitamin D’s impact on innate immunity, it has received attention 
recently about the possibility of improvement of eczema with supplementation.9 Current 
recommended daily doses of vitamin D range from 800 IU per day to beyond 4000 IU per 
day, depending on the extent of insufficiency. Vitamin D levels are often varied among 
persons of differing skin shades, geographic locations, sunscreen use habits, diet, and 
hereditary factors.7 The multifactorial nature of vitamin D levels makes studying their 
effects on atopic dermatitis difficult. 
 Traditional treatment options for patients with atopic dermatitis include harmful 
ultraviolet B light treatment and/or topical vitamin D. These treatments may be effective 
due to the possible activation of the production of vitamin D3 in the skin.10 Ultraviolet 
light is a known cancer-causing agent and should not be used routinely to treat eczema in 
most patients. In addition, topical application of vitamin D has not been shown to 
significantly affect the symptomology of sufferers of atopic dermatitis.10 Recent research 
focus has been on oral supplementation of vitamin D, especially in higher latitude regions 
where vitamin D deficiency is widespread. Pilot studies11,2 are revealing a possible 
correlation to decreased serum vitamin D levels and increased severity of eczema, using 
SCORing Atopic Dermatitis (SCORAD) and Three-Item Severity (TIS) scales.  
 Patients often are interested in an adjunct or more natural method of treating a 
disorder and vitamin supplementation has been used for centuries in this manner.10 
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Vitamin D is relatively affordable and well-tolerated with little to no risk in most patients 
and may be able to increase the quality of life of those who are affected by atopic 
dermatitis.3 Can vitamin D supplementation improve eczema severity? 
METHODS 
 An exhaustive search of relevant medical articles was conducted utilizing the 
following search engines: MEDLINE-OVID, Web of Science, and CINAHL through the 
Pacific University Library Databases using keywords “vitamin D,” and “atopic 
dermatitis.” The search produced 108 articles that was narrowed by the following 
exclusion criteria: studies in the English language, random control trials with placebo 
groups and number of participants over 30, and studies conducted within the past three 
years. The abstracts and titles were used to narrow down the relevant studies for inclusion 
in the review to three articles. Relevant articles were assessed for relevance and quality 
using the Grading of Recommendations, Assessment and Development of Evaluation 
(GRADE).12 A search of the National Institutes of Health (NIH) revealed that there are 
no current studies or related trials examining the effects of vitamin D supplementation on 
atopic dermatitis symptomology.   
RESULTS 
 The initial database search yielded 108 articles that were relevant using the 
keywords “atopic dermatitis,” and “vitamin D.” Once applying the inclusion criteria 
described above, two articles1,8 remained to include in the systematic review. Two RCTs 
were examined to review if vitamin D supplementation improves atopic dermatitis. See 
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Table I. One study7 was excluded because the authors did not fully separate the results of 
atopic dermatitis from other groups in regards to vitamin D supplementation. 
Amestejani et al 
 This randomized, double blind study1 examined vitamin D supplementation in the 
treatment of atopic dermatitis in Iran in 2012 and was lead by Morteza Amestejani, MD. 
The purpose of the clinical trial was to evaluate the effects of vitamin D supplementation 
on symptomology in patients with atopic dermatitis. Sixty subjects began the study, with 
30 in the vitamin D group and 30 in the placebo group which was randomized by a third 
party who was not involved with the trial. Group allocation was processed by a 
computer-generated program, which randomly assigned group numbers. These groups 
were randomized and group allocation was concealed. The trial was 60 days in length and 
the treatment group received 1600 IU of cholecalciferol (vitamin D3) daily. The severity 
of atopic dermatitis was measured using SCORAD and TIS values by the same trained 
physician before and after the trial.1  
 The inclusion criteria included being over age 14 years with no systemic diseases, 
concomitant systemic pyretic or inflammatory processes, other than diabetes mellitus and 
chronic hepatitis.1 The exclusion criteria were pregnancy; systemic inflammatory disease; 
taking vitamins, minerals or supplements, oral contraceptive pills, steroid hormones, anti-
epileptic agents, and anticoagulant drugs; and nursing mothers. The researchers did allow 
continuation of prescribed medications, both orally and topically that patients were 
already using specifically for atopic dermatitis treatment.1 
 The SCORAD grading of severity of eczema is divided into three grades of 
severity: mild (<15 points), moderate (15-40 points), and severe atopic dermatitis (>40 
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points). The TIS value of severity is assessed by the following for the three divisions: 
mild (0-2 points), moderate (3-5 points), and severe form (6-9 points). Statistics were 
completed using SPSS software and a p-value of <0.05 was considered statistically 
significant.1 
 At the end of the 60-day trial, 29 patients remained in the treatment group and 24 
in the placebo group. The seven participants were excluded from statistical analyses at 
the end of the study. The age, height, weight, SCORAD index, and TIS value of the two 
groups did not differ significantly at the beginning of the study with a p<0.05.1 
 Amestejani, et al1 found that at the conclusion of the study, all three groups of 
patients with calculated mild, moderate, and severe SCORAD and TIS atopic dermatitis 
symptoms were improved after 60 days of supplementation at a p<0.05 level. See Table 
II. The placebo group did not show any significant changes in their SCORAD and TIS 
symptoms of atopic dermatitis at a p>0.05 level. These results confirmed their hypothesis 
that vitamin D supplementation did improve atopic dermatitis symptoms. The authors 
suggest that vitamin D has both enhancing and protective mechanisms of the skin and 
these qualities could possibly benefit patients who suffer from atopic dermatitis.1 
 The authors identified and reported a few limitations. A limitation of the study 
was that there was only one dose of vitamin D supplementation given during the trial. 
This did not help identify a therapeutic dose to recommend in order to meet a therapeutic 
threshold. It would also be helpful to have a study that was longer in duration to 
understand whether the protective mechanisms that vitamin D supplies to the skin are 
continual or need to be constantly supplemented in order to be achieved.1 
Javanbakht et al 
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 Javanbakht et al8 conducted a randomized controlled trial using vitamins E and D 
supplementation in atopic dermatitis that was published in the Journal of Dermatological 
Treatment in 2011. Forty-five subjects were divided into four groups which consisted of 
group P (placebo), 1600 IU of vitamin D supplementation for group D, 600 IU of vitamin 
E was for group E, and group DE was 1600 IU of vitamin D and 600 IU of vitamin E 
combined for 60 days. The pills were identical in size and shape and the patients were 
randomized into groups for which they remained in for the duration of the study.8  
 The trial measured clinical improvement of atopic dermatitis using SCORAD and 
also measured serum levels of vitamin D and E before and after the study. The four 
groups were randomized to each group and allocation was concealed. The authors 
included patients with atopic dermatitis who had an initial score of 10-70 on the 
SCORAD scale between the ages of 13-45 years old. Exclusion criteria included patients 
taking vitamins, mineral and fatty acid supplements, oral contraceptive pills, steroid 
hormones, and anti-epileptic agents, pregnant or nursing mothers, and those who were on 
anticoagulant medications. The patients were encouraged to maintain their prescribed 
treatments for their atopic dermatitis, which may have included emollients, topical 
corticosteroids, and oral antihistamines.8   
 The authors used one-way analysis of variance (ANOVA), ANCOVA, Kruskal-
Wallis test and chi-squared tests to compute differences between groups and to look for 
significance. They used a p-value of <0.05 for significance and they utilized SPSS 
software. Forty-five out of the fifty-two participants completed the study and those that 
were lost were not included in the final calculations. The groups were not significantly 
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different at the beginning of the study including age, sex, SCORAD index, and topical 
corticosteroidal usage at baseline at p<0.05 level.8   
 In the intent-to-treat analysis, the results show an overall improvement in 
SCORAD in all four groups: 24%, 32%, 30%, and 54.4% for groups P, D, E, and DE, 
respectively, with a p-value of 0.032 at the completion of the trial. These reductions were 
significant, but include changes in the placebo group in addition to the treatment groups. 
In the per-protocol analysis, groups D, E and DE showed a significant reduction in 
SCORAD values of 34.8%, 35.7%, and 64.3% with a p-value of 0.004. Despite these 
improvements, the difference between groups P and D was not significant. The need for 
use of topical corticosteroids was decreased in all four groups, but least in the placebo 
group. Limitations discussed by the authors include a small sample size and only one 
dose of treatment (1600 IU vitamin D).8 
DISCUSSION 
 Vitamin D seems to play an important role in the innate immunity process but 
little is actually known about its effects on skin and skin conditions.3 There are few 
background studies that examine the link between inflammation and vitamin D 
supplementation. The exact link is still controversial and sometimes even refuted 
altogether. The two studies1,8 that are reviewed show that a possible link exists, albeit 
small according to the compiled data.  
 Amestejani et al1 found that 1600 IU of cholecalciferol supplementation over 60 
days did significantly improve the symptoms of AD in patients with mild, moderate, and 
severe atopic dermatitis. Similarly, Javanbakht et al8 found a reduction in symptoms in 
patients with AD after supplementation with vitamin D, however the differences between 
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the placebo and group with vitamin D were not significant. However, whether or not 
1600 IU of cholecalciferol is the most effective dose in treating atopic dermatitis was not 
established with these studies. Moreover, the Javanbakht et al8 study demonstrated a 
lower need for topical corticosteroids with vitamin D supplementation and a possible 
synergistic benefit with the addition of vitamin E. 
 Vitamin D supplementation is a relatively safe, inexpensive option with potential 
to decrease symptomology in those patients who suffer from atopic dermatitis. The risk 
of vitamin toxicity is rarely seen. Occasionally a medical provider will find it in a patient 
who exhibits symptoms of hypercalcemia and is usually associated with medications that 
promote imbalances in calcium, not from overly aggressive vitamin D supplementation.10 
Experts believe that the dose required to bring upon vitamin D toxicity is about 10 000 IU 
per day, which is far from even the upper end of aggressive vitamin D supplementation 
practices.10 Considering the known negative effects on immunity and specifically the 
possible relief in symptomology of eczema, medical providers should consider vitamin D 
supplementation in patients suffering from atopic dermatitis until further research is 
completed. 
 Both studies suffered from a somewhat small sample size with the Javanbakht et 
al8 study having 45 participants who were divided into four groups which made this 
study’s precision suspect. Another limitation was that only one dose of vitamin D was 
utilized which limits the ability to identify the most effective dose or whether or not more 
improvement is seen in higher but safe doses of vitamin D. Lastly, the results that were 
reported lacked a between group comparison to the extent where a magnitude of effect 
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could be ascertained (eg, relative risk and number-needed-to-treat). This results in an 
overall moderate quality of evidence (see Table I). 
 Implication for further research is supported by the studies’ results that show 
improved SCORAD and TIS scores, however not all were significant. Support for 
vitamin D supplementation would be bolstered with longer and more robust randomized 
controlled trials that include other vitamin D doses and reported the number of 
participants who improved on the therapy. More research is needed to confirm if vitamin 
D supplementation does in fact improve symptoms of atopic dermatitis and whether the 
addition of other vitamins (eg, vitamin E) would also benefit these patients. 
CONCLUSION 
 Medical providers can now use the data regarding vitamin D’s role in immunity 
and systemic disease prevention to more aggressively treat vitamin D deficiency in their 
patients. The clinical practice implication of the review shows that vitamin D could play 
an additive role in the protection of the skin barrier that is affected by immunity and 
atopic dermatitis. Eczema is one of the most common skin disorders in children and 
adults alike and the traditional treatments often do not bring relief. Vitamin D 
supplementation is a relatively safe, inexpensive option with potential to decrease 
symptomology in those patients who suffer from atopic dermatitis. The studies that were 
reviewed for this paper show some promise that vitamin D can help decrease the 
symptoms of atopic dermatitis when used in dermatology clinics worldwide.1,8  More 
research must be completed to examine the therapeutic dose that brings the greatest 
benefit for patients, and what other factors could be added to vitamin supplementation in 
order to maximize treatment of eczema.
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Table I. Characteristics of Reviewed Studies 
 
 
a Small sample size 
 
 
 
 
 
 
Table II. SCORAD and TIS Values1 
 
             Before                  After                  p-value 
SCORAD 
Index 
Drug G Mean Score  
24.8+/-4.1 
 
15.3+/-3.1 
 
0.01 
 Placebo G Mean Score 25.3+/-5.2 23.46+/-4.2 0.15 
TIS Value Drug G Total Score 3.5+/-0.5 1.9+/-0.4 0.032 
 Placebo G Total Score 3.8+/-0.4 4.02+/-0.5 0.22 
 
 
Quality Assessment  
 Downgrade Criteria 
Quality 
Study Design Limitations Indirectness Imprecision Inconsistency Publication bias likely 
Vitamin D Supplementation   Moderate 
Amestejani 
et al1 RCT Not serious
 Not serious Not serious Not serious No High 
Javanbakht 
et al8 RCT Not serious
 Not serious Seriousa Not serious No Moderate 
